Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Heterogenized Pyridine-Substituted Cobalt(II) Phthalocyanine Yields Reduction of CO2 by Tuning the Electron Affinity of the Co Center.

De Riccardis A, Lee M, Kazantsev RV, Garza AJ, Zeng G, Larson DM, Clark EL, Lobaccaro P, Burroughs PWW, Bloise E, Ager JW, Bell AT, Head-Gordon M, Mele G, Toma FM.

ACS Appl Mater Interfaces. 2020 Feb 5;12(5):5251-5258. doi: 10.1021/acsami.9b18924. Epub 2020 Jan 23.

PMID:
31971360
2.

Nanomaterials Based on Fe3O4 and Phthalocyanines Derived from Cashew Nut Shell Liquid.

Ribeiro VGP, Mota JPF, Júnior AEC, Lima NMA, Fechine PBA, Denardin JC, Carbone L, Bloise E, Mele G, Mazzetto SE.

Molecules. 2019 Sep 9;24(18). pii: E3284. doi: 10.3390/molecules24183284.

3.

Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'.

Mele G, Pastore D, Di Renzo N, Fragasso A, Guarini A, Mazza P, Musto P, Pavone V, Tarantini G, Curci P, Falcone AP, Mele A, Miccolis MR, Palazzo G, Palumbo G, Quinto AM, Reddiconto G, Rizzi R, Cascavilla N, Specchia G, Capalbo SF.

Leuk Lymphoma. 2019 Dec;60(14):3565-3568. doi: 10.1080/10428194.2019.1636989. Epub 2019 Jul 9. No abstract available.

PMID:
31286780
4.

Light-Emitting Porphyrin Derivative Obtained from a Subproduct of the Cashew Nut Shell Liquid: A Promising Material for OLED Applications.

de Amorim Lima NM, Camargo Avila HJ, do Nascimento Marchiori CF, Gondim Sampaio S, Ferreira Mota JP, Gomes Pereira Ribeiro V, da Silva Clemente C, Mele G, Cremona M, Mazzetto SE.

Materials (Basel). 2019 Apr 1;12(7). pii: E1063. doi: 10.3390/ma12071063.

5.

Efficacy of Carfilzomib, Lenalidomide, and Dexamethasone for Extramedullary Intracranial Localization of Multiple Myeloma.

Mele G, Pastore D.

Case Rep Hematol. 2018 Nov 29;2018:2312430. doi: 10.1155/2018/2312430. eCollection 2018.

6.

Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients.

Jurczyszyn A, Castillo JJ, Avivi I, Czepiel J, Davila J, Vij R, Fiala MA, Gozzetti A, Grząśko N, Milunovic V, Hus I, Mądry K, Waszczuk-Gajda A, Usnarska-Zubkiewicz L, Dębski J, Atilla E, Beksac M, Mele G, Sawicki W, Jayabalan D, Charliński G, Gyula Szabo A, Hajek R, Delforge M, Kopacz A, Fantl D, Waage A, Crusoe E, Hungria V, Richardson P, Laubach J, Guerrero-Garcia T, Liu J, Vesole DH.

Leuk Lymphoma. 2019 Jan;60(1):118-123. doi: 10.1080/10428194.2018.1473574. Epub 2018 Jul 2.

PMID:
29965787
7.

Improved Photo-Ignition of Carbon Nanotubes/Ferrocene Using a Lipophilic Porphyrin under White Power LED Irradiation.

Visconti P, Primiceri P, de Fazio R, Carlucci AP, Mazzetto SE, Mele G.

Materials (Basel). 2018 Jan 13;11(1). pii: E127. doi: 10.3390/ma11010127.

8.

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.

Olivieri J, Attolico I, Nuccorini R, Pascale SP, Chiarucci M, Poiani M, Corradini P, Farina L, Gaidano G, Nassi L, Sica S, Piccirillo N, Pioltelli PE, Martino M, Moscato T, Pini M, Zallio F, Ciceri F, Marktel S, Mengarelli A, Musto P, Capria S, Merli F, Codeluppi K, Mele G, Lanza F, Specchia G, Pastore D, Milone G, Saraceni F, Di Nardo E, Perseghin P, Olivieri A.

Bone Marrow Transplant. 2018 Apr;53(4):461-473. doi: 10.1038/s41409-017-0051-y. Epub 2018 Jan 12.

9.

Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.

Jurczyszyn A, Radocha J, Davila J, Fiala MA, Gozzetti A, Grząśko N, Robak P, Hus I, Waszczuk-Gajda A, Guzicka-Kazimierczak R, Atilla E, Mele G, Sawicki W, Jayabalan DS, Charliński G, Szabo AG, Hajek R, Delforge M, Kopacz A, Fantl D, Waage A, Avivi I, Rodzaj M, Leleu X, Richez V, Knopińska-Posłuszny W, Masternak A, Yee AJ, Barchnicka A, Druzd-Sitek A, Guerrero-Garcia T, Liu J, Vesole DH, Castillo JJ.

Br J Haematol. 2018 Mar;180(6):831-839. doi: 10.1111/bjh.15092. Epub 2018 Jan 7.

PMID:
29315478
10.

A New Ion-Imprinted Chitosan-Based Membrane with an Azo-Derivative Ligand for the Efficient Removal of Pd(II).

Di Bello MP, Lazzoi MR, Mele G, Scorrano S, Mergola L, Del Sole R.

Materials (Basel). 2017 Sep 26;10(10). pii: E1133. doi: 10.3390/ma10101133.

11.

New ZnO@Cardanol Porphyrin Composite Nanomaterials with Enhanced Photocatalytic Capability under Solar Light Irradiation.

Ribeiro VGP, Marcelo AMP, da Silva KT, da Silva FLF, Mota JPF, do Nascimento JPC, Sombra ASB, Clemente CDS, Mele G, Carbone L, Mazzetto SE.

Materials (Basel). 2017 Sep 21;10(10). pii: E1114. doi: 10.3390/ma10101114.

12.

Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study.

Jurczyszyn A, Gozzetti A, Gdula-Argasińska J, Czepiel J, Vij R, Fiala M, Valls DJ, Mądry K, Waszczuk-Gajda A, Grosicki S, Barchnicka A, Crusoe E, Hungria V, Gentile M, Mele G, Ksieniewicz M, Vesole DH, Castillo JJ.

Ann Hematol. 2017 Oct;96(10):1693-1698. doi: 10.1007/s00277-017-3084-9. Epub 2017 Aug 1.

PMID:
28766002
13.

Photo-ignition process of multiwall carbon nanotubes and ferrocene by continuous wave Xe lamp illumination.

Visconti P, Primiceri P, Longo D, Strafella L, Carlucci P, Lomascolo M, Cretì A, Mele G.

Beilstein J Nanotechnol. 2017 Jan 13;8:134-144. doi: 10.3762/bjnano.8.14. eCollection 2017.

14.

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study.

Pozzi S, Gentile M, Sacchi S, Marcheselli R, Corso A, Cocito F, Musto P, Guarini A, Minoia C, Vincelli I, Ria R, Rivolti E, Mele G, Bari A, Mazzone C, Badiali S, Marcheselli L, Palumbo A, Morabito F.

Leuk Lymphoma. 2017 Mar;58(3):552-559. doi: 10.1080/10428194.2016.1205741. Epub 2016 Jul 21.

PMID:
27442600
15.

Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.

Jurczyszyn A, Olszewska-Szopa M, Hungria V, Crusoe E, Pika T, Delforge M, Leleu X, Rasche L, Nooka AK, Druzd-Sitek A, Walewski J, Davila J, Caers J, Maisnar V, Gertz M, Gentile M, Fantl D, Mele G, Vesole DH, Yee AJ, Shustik C, Lentzsch S, Zweegman S, Gozzetti A, Skotnicki AB, Castillo JJ.

Leuk Lymphoma. 2016 Sep;57(9):2071-6. doi: 10.3109/10428194.2015.1128542. Epub 2016 Jan 4.

PMID:
26726867
16.

Response to pomalidomide plus fixed low-dose dexamethasone in a case of secondary plasma cell leukaemia.

Mele G, Coppi MR, Guaragna G, Spina A, Melpignano A.

Leuk Res. 2016 Jan;40:30-2. doi: 10.1016/j.leukres.2015.11.009. Epub 2015 Nov 25.

PMID:
26626205
17.

Bendamustine in relapsed/refractory multiple myeloma: the "real-life" side of the moon.

Musto P, Fraticelli VL, Mansueto G, Madonna E, Nozza A, Andriani A, Mussetti A, Ballanti S, Bongarzoni V, Baraldi A, Patriarca F, Vincelli D, Falcone A, Derudas D, Califano C, Zambello R, Mele G, Fragasso A, Baldini L, Storti S.

Leuk Lymphoma. 2015 May;56(5):1510-3. doi: 10.3109/10428194.2014.982644. Epub 2015 Mar 3. No abstract available.

PMID:
25651428
18.

Paralytic ileus following "subcutaneous bortezomib" therapy: focus on the clinical emergency-report of two cases.

Mele G, Coppi MR, Melpignano A, Quarta G.

Clin Exp Med. 2016 Feb;16(1):99-101. doi: 10.1007/s10238-015-0337-6. Epub 2015 Jan 20.

PMID:
25600700
19.

Photoreduction of carbon dioxide to formic acid in aqueous suspension: a comparison between phthalocyanine/TiO2 and porphyrin/TiO2 catalysed processes.

Mele G, Annese C, D'Accolti L, De Riccardis A, Fusco C, Palmisano L, Scarlino A, Vasapollo G.

Molecules. 2014 Dec 30;20(1):396-415. doi: 10.3390/molecules20010396.

20.

Response to lung ultrasound as an additional imaging tool for the evaluation of pneumonia.

Caiulo VA, Gargani L, Caiulo S, Fisicaro A, Moramarco F, Latini G, Picano E, Mele G.

Pediatr Pulmonol. 2014 Jun;49(6):619-20. doi: 10.1002/ppul.23009. Epub 2014 Feb 16. No abstract available.

PMID:
24532447

Supplemental Content

Loading ...
Support Center